Abstract
We studied the effect of 2 weeks administration of the 5-HT2C receptor agonist, m-chlorophenylpiperazine (mCPP), on appetite and body weight in 18 moderately obese subjects in a double-blind, placebo-controlled trial. mCPP caused a small but significant (0.75 kg) reduction in body weight and in subjective ratings of hunger. Plasma prolactin was significantly elevated by the final dose of mCPP. Our data suggest that during 2 weeks treatment in humans, mCPP may continue to activate brain 5-HT2C receptors, and that this effect is associated with decreases in appetite and body weight.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 20 May 1997 /Final version: 10 July 1997
Rights and permissions
About this article
Cite this article
Sargent, P., Sharpley, A., Williams, C. et al. 5-HT2C receptor activation decreases appetite and body weight in obese subjects. Psychopharmacology 133, 309–312 (1997). https://doi.org/10.1007/s002130050407
Issue Date:
DOI: https://doi.org/10.1007/s002130050407